mouse stat3 Search Results


solid phase sandwich elisa kit  (R&D Systems)
94
R&D Systems solid phase sandwich elisa kit
Solid Phase Sandwich Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/solid phase sandwich elisa kit/product/R&D Systems
Average 94 stars, based on 1 article reviews
solid phase sandwich elisa kit - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
stat3  (Cell Signaling Technology Inc)
99
Cell Signaling Technology Inc stat3
Stat3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stat3/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
stat3 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
anti phosphorylated stat3 y705 antibody  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc anti phosphorylated stat3 y705 antibody
Fig. 1 | PRMT5 expression levels are increased in lung cancer cells. a, b PRMT5 expression is elevated in a lung adenocarcinoma and b lung squamous cell carci- noma. RNA-seq data from The Cancer Genome Atlas (TCGA) were analysed on the UCSC Xena browser. c Correlation between <t>STAT3</t> and PRMT5 protein levels in 12 NSCLC cell lines (NCI-H23, LU65, CORL105, CHAGOK1, NCI-H3255, NCI-
Anti Phosphorylated Stat3 Y705 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti phosphorylated stat3 y705 antibody/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
anti phosphorylated stat3 y705 antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
p stat3  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc p stat3
Fig. 1 | PRMT5 expression levels are increased in lung cancer cells. a, b PRMT5 expression is elevated in a lung adenocarcinoma and b lung squamous cell carci- noma. RNA-seq data from The Cancer Genome Atlas (TCGA) were analysed on the UCSC Xena browser. c Correlation between <t>STAT3</t> and PRMT5 protein levels in 12 NSCLC cell lines (NCI-H23, LU65, CORL105, CHAGOK1, NCI-H3255, NCI-
P Stat3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p stat3/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
p stat3 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
monoclonal mouse anti stat3 antibody  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc monoclonal mouse anti stat3 antibody
Fig. 1 | PRMT5 expression levels are increased in lung cancer cells. a, b PRMT5 expression is elevated in a lung adenocarcinoma and b lung squamous cell carci- noma. RNA-seq data from The Cancer Genome Atlas (TCGA) were analysed on the UCSC Xena browser. c Correlation between <t>STAT3</t> and PRMT5 protein levels in 12 NSCLC cell lines (NCI-H23, LU65, CORL105, CHAGOK1, NCI-H3255, NCI-
Monoclonal Mouse Anti Stat3 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal mouse anti stat3 antibody/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
monoclonal mouse anti stat3 antibody - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
mouse anti human phosphoserine stat3  (Cell Signaling Technology Inc)
93
Cell Signaling Technology Inc mouse anti human phosphoserine stat3
Fig. 1 | PRMT5 expression levels are increased in lung cancer cells. a, b PRMT5 expression is elevated in a lung adenocarcinoma and b lung squamous cell carci- noma. RNA-seq data from The Cancer Genome Atlas (TCGA) were analysed on the UCSC Xena browser. c Correlation between <t>STAT3</t> and PRMT5 protein levels in 12 NSCLC cell lines (NCI-H23, LU65, CORL105, CHAGOK1, NCI-H3255, NCI-
Mouse Anti Human Phosphoserine Stat3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti human phosphoserine stat3/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
mouse anti human phosphoserine stat3 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
mr227265 pcmv6 entry origene  (OriGene)
90
OriGene mr227265 pcmv6 entry origene
Fig. 1 | PRMT5 expression levels are increased in lung cancer cells. a, b PRMT5 expression is elevated in a lung adenocarcinoma and b lung squamous cell carci- noma. RNA-seq data from The Cancer Genome Atlas (TCGA) were analysed on the UCSC Xena browser. c Correlation between <t>STAT3</t> and PRMT5 protein levels in 12 NSCLC cell lines (NCI-H23, LU65, CORL105, CHAGOK1, NCI-H3255, NCI-
Mr227265 Pcmv6 Entry Origene, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mr227265 pcmv6 entry origene/product/OriGene
Average 90 stars, based on 1 article reviews
mr227265 pcmv6 entry origene - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
stat3  (R&D Systems)
93
R&D Systems stat3
Fig. 7 Galectin-3 expression induces activation of PYK2, STAT1 and GSK3α/β signalling. Expression of 37 protein kinases in SW620 cells in response to 10 µg/ml galectin-3 or BSA for 0.5 h was assessed by Proteome Profiler Human Phospho-Kinase Array (A, Percentage changes of the kinases in cell response to galectin-3 in comparison to control are shown at the bottom panel). The presence of galectin-3 increases the phosphorylation of PYK2, GSK3α/β, and STAT1 and decreases phosphorylation of <t>STAT3.</t> SW620 cells treated with 10 µg/ml galectin-3 for different times were assessed by immunoblotting using antibodies against p-PYK2, p-STAT-1, p-GSK3α/β or p-STAT-3 (B). The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The band density was quantified and expressed as percentages of phospho-/non-phosphorylated proteins (C). In D and E, SW620 cells were treated with 10 µg/ml galectin-3 or BSA followed by introduction of GSK3α/β inhibitor SB 216763 (SB) or PKY2 inhibitor PF-431396 (PF) for 15 min and the levels of phosphorylated PYK2, STAT-1, GSK3α/β or STAT-3 were analysed by immunoblotting. The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The densities of the blots from three independent experiments were quantified and are expressed as the percentage of phosphorylated/non-phosphorylated levels of each protein. ***P < 0.001, **P < 0.01, *P < 0.05 (ANOVA).
Stat3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stat3/product/R&D Systems
Average 93 stars, based on 1 article reviews
stat3 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
anti stat3  (R&D Systems)
92
R&D Systems anti stat3
Fig. 7 Galectin-3 expression induces activation of PYK2, STAT1 and GSK3α/β signalling. Expression of 37 protein kinases in SW620 cells in response to 10 µg/ml galectin-3 or BSA for 0.5 h was assessed by Proteome Profiler Human Phospho-Kinase Array (A, Percentage changes of the kinases in cell response to galectin-3 in comparison to control are shown at the bottom panel). The presence of galectin-3 increases the phosphorylation of PYK2, GSK3α/β, and STAT1 and decreases phosphorylation of <t>STAT3.</t> SW620 cells treated with 10 µg/ml galectin-3 for different times were assessed by immunoblotting using antibodies against p-PYK2, p-STAT-1, p-GSK3α/β or p-STAT-3 (B). The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The band density was quantified and expressed as percentages of phospho-/non-phosphorylated proteins (C). In D and E, SW620 cells were treated with 10 µg/ml galectin-3 or BSA followed by introduction of GSK3α/β inhibitor SB 216763 (SB) or PKY2 inhibitor PF-431396 (PF) for 15 min and the levels of phosphorylated PYK2, STAT-1, GSK3α/β or STAT-3 were analysed by immunoblotting. The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The densities of the blots from three independent experiments were quantified and are expressed as the percentage of phosphorylated/non-phosphorylated levels of each protein. ***P < 0.001, **P < 0.01, *P < 0.05 (ANOVA).
Anti Stat3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti stat3/product/R&D Systems
Average 92 stars, based on 1 article reviews
anti stat3 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
stat3  (OriGene)
94
OriGene stat3
Fig. 7 Galectin-3 expression induces activation of PYK2, STAT1 and GSK3α/β signalling. Expression of 37 protein kinases in SW620 cells in response to 10 µg/ml galectin-3 or BSA for 0.5 h was assessed by Proteome Profiler Human Phospho-Kinase Array (A, Percentage changes of the kinases in cell response to galectin-3 in comparison to control are shown at the bottom panel). The presence of galectin-3 increases the phosphorylation of PYK2, GSK3α/β, and STAT1 and decreases phosphorylation of <t>STAT3.</t> SW620 cells treated with 10 µg/ml galectin-3 for different times were assessed by immunoblotting using antibodies against p-PYK2, p-STAT-1, p-GSK3α/β or p-STAT-3 (B). The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The band density was quantified and expressed as percentages of phospho-/non-phosphorylated proteins (C). In D and E, SW620 cells were treated with 10 µg/ml galectin-3 or BSA followed by introduction of GSK3α/β inhibitor SB 216763 (SB) or PKY2 inhibitor PF-431396 (PF) for 15 min and the levels of phosphorylated PYK2, STAT-1, GSK3α/β or STAT-3 were analysed by immunoblotting. The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The densities of the blots from three independent experiments were quantified and are expressed as the percentage of phosphorylated/non-phosphorylated levels of each protein. ***P < 0.001, **P < 0.01, *P < 0.05 (ANOVA).
Stat3, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stat3/product/OriGene
Average 94 stars, based on 1 article reviews
stat3 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
anti stat3 fitc  (R&D Systems)
90
R&D Systems anti stat3 fitc
Fig. 7 Galectin-3 expression induces activation of PYK2, STAT1 and GSK3α/β signalling. Expression of 37 protein kinases in SW620 cells in response to 10 µg/ml galectin-3 or BSA for 0.5 h was assessed by Proteome Profiler Human Phospho-Kinase Array (A, Percentage changes of the kinases in cell response to galectin-3 in comparison to control are shown at the bottom panel). The presence of galectin-3 increases the phosphorylation of PYK2, GSK3α/β, and STAT1 and decreases phosphorylation of <t>STAT3.</t> SW620 cells treated with 10 µg/ml galectin-3 for different times were assessed by immunoblotting using antibodies against p-PYK2, p-STAT-1, p-GSK3α/β or p-STAT-3 (B). The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The band density was quantified and expressed as percentages of phospho-/non-phosphorylated proteins (C). In D and E, SW620 cells were treated with 10 µg/ml galectin-3 or BSA followed by introduction of GSK3α/β inhibitor SB 216763 (SB) or PKY2 inhibitor PF-431396 (PF) for 15 min and the levels of phosphorylated PYK2, STAT-1, GSK3α/β or STAT-3 were analysed by immunoblotting. The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The densities of the blots from three independent experiments were quantified and are expressed as the percentage of phosphorylated/non-phosphorylated levels of each protein. ***P < 0.001, **P < 0.01, *P < 0.05 (ANOVA).
Anti Stat3 Fitc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti stat3 fitc/product/R&D Systems
Average 90 stars, based on 1 article reviews
anti stat3 fitc - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
elisa  (R&D Systems)
93
R&D Systems elisa
Fig. 7 Galectin-3 expression induces activation of PYK2, STAT1 and GSK3α/β signalling. Expression of 37 protein kinases in SW620 cells in response to 10 µg/ml galectin-3 or BSA for 0.5 h was assessed by Proteome Profiler Human Phospho-Kinase Array (A, Percentage changes of the kinases in cell response to galectin-3 in comparison to control are shown at the bottom panel). The presence of galectin-3 increases the phosphorylation of PYK2, GSK3α/β, and STAT1 and decreases phosphorylation of <t>STAT3.</t> SW620 cells treated with 10 µg/ml galectin-3 for different times were assessed by immunoblotting using antibodies against p-PYK2, p-STAT-1, p-GSK3α/β or p-STAT-3 (B). The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The band density was quantified and expressed as percentages of phospho-/non-phosphorylated proteins (C). In D and E, SW620 cells were treated with 10 µg/ml galectin-3 or BSA followed by introduction of GSK3α/β inhibitor SB 216763 (SB) or PKY2 inhibitor PF-431396 (PF) for 15 min and the levels of phosphorylated PYK2, STAT-1, GSK3α/β or STAT-3 were analysed by immunoblotting. The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The densities of the blots from three independent experiments were quantified and are expressed as the percentage of phosphorylated/non-phosphorylated levels of each protein. ***P < 0.001, **P < 0.01, *P < 0.05 (ANOVA).
Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa/product/R&D Systems
Average 93 stars, based on 1 article reviews
elisa - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 1 | PRMT5 expression levels are increased in lung cancer cells. a, b PRMT5 expression is elevated in a lung adenocarcinoma and b lung squamous cell carci- noma. RNA-seq data from The Cancer Genome Atlas (TCGA) were analysed on the UCSC Xena browser. c Correlation between STAT3 and PRMT5 protein levels in 12 NSCLC cell lines (NCI-H23, LU65, CORL105, CHAGOK1, NCI-H3255, NCI-

Journal: Communications biology

Article Title: PRMT5-mediated methylation of STAT3 is required for lung cancer stem cell maintenance and tumour growth.

doi: 10.1038/s42003-024-06290-7

Figure Lengend Snippet: Fig. 1 | PRMT5 expression levels are increased in lung cancer cells. a, b PRMT5 expression is elevated in a lung adenocarcinoma and b lung squamous cell carci- noma. RNA-seq data from The Cancer Genome Atlas (TCGA) were analysed on the UCSC Xena browser. c Correlation between STAT3 and PRMT5 protein levels in 12 NSCLC cell lines (NCI-H23, LU65, CORL105, CHAGOK1, NCI-H3255, NCI-

Article Snippet: STAT3 activation was monitored by western blotting using an anti-phosphorylated STAT3 (Y705) antibody (CST; 9138).

Techniques: Expressing, RNA Sequencing

Fig. 7 Galectin-3 expression induces activation of PYK2, STAT1 and GSK3α/β signalling. Expression of 37 protein kinases in SW620 cells in response to 10 µg/ml galectin-3 or BSA for 0.5 h was assessed by Proteome Profiler Human Phospho-Kinase Array (A, Percentage changes of the kinases in cell response to galectin-3 in comparison to control are shown at the bottom panel). The presence of galectin-3 increases the phosphorylation of PYK2, GSK3α/β, and STAT1 and decreases phosphorylation of STAT3. SW620 cells treated with 10 µg/ml galectin-3 for different times were assessed by immunoblotting using antibodies against p-PYK2, p-STAT-1, p-GSK3α/β or p-STAT-3 (B). The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The band density was quantified and expressed as percentages of phospho-/non-phosphorylated proteins (C). In D and E, SW620 cells were treated with 10 µg/ml galectin-3 or BSA followed by introduction of GSK3α/β inhibitor SB 216763 (SB) or PKY2 inhibitor PF-431396 (PF) for 15 min and the levels of phosphorylated PYK2, STAT-1, GSK3α/β or STAT-3 were analysed by immunoblotting. The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The densities of the blots from three independent experiments were quantified and are expressed as the percentage of phosphorylated/non-phosphorylated levels of each protein. ***P < 0.001, **P < 0.01, *P < 0.05 (ANOVA).

Journal: Cell death & disease

Article Title: Galectin-3 promotes secretion of proteases that decrease epithelium integrity in human colon cancer cells.

doi: 10.1038/s41419-023-05789-x

Figure Lengend Snippet: Fig. 7 Galectin-3 expression induces activation of PYK2, STAT1 and GSK3α/β signalling. Expression of 37 protein kinases in SW620 cells in response to 10 µg/ml galectin-3 or BSA for 0.5 h was assessed by Proteome Profiler Human Phospho-Kinase Array (A, Percentage changes of the kinases in cell response to galectin-3 in comparison to control are shown at the bottom panel). The presence of galectin-3 increases the phosphorylation of PYK2, GSK3α/β, and STAT1 and decreases phosphorylation of STAT3. SW620 cells treated with 10 µg/ml galectin-3 for different times were assessed by immunoblotting using antibodies against p-PYK2, p-STAT-1, p-GSK3α/β or p-STAT-3 (B). The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The band density was quantified and expressed as percentages of phospho-/non-phosphorylated proteins (C). In D and E, SW620 cells were treated with 10 µg/ml galectin-3 or BSA followed by introduction of GSK3α/β inhibitor SB 216763 (SB) or PKY2 inhibitor PF-431396 (PF) for 15 min and the levels of phosphorylated PYK2, STAT-1, GSK3α/β or STAT-3 were analysed by immunoblotting. The blots were striped and reprobed with antibodies against PYK2, STAT-1, GSK3α/β or STAT-3. The densities of the blots from three independent experiments were quantified and are expressed as the percentage of phosphorylated/non-phosphorylated levels of each protein. ***P < 0.001, **P < 0.01, *P < 0.05 (ANOVA).

Article Snippet: Biotinylated-anti-galectin-3 (BAF1154) antibody and antibodies against galectin-3 (MAB1154), STAT1 (MAB1490), Phospho-STAT1(MAB2894), STAT3 (MAB1799), Phospho-STAT3 (MAB4934), PYK2 (AF4589), phosphorPYK2 (MAB6210), GSK3α/β (AF2157), Phospho-GSK3α/β (AF1590); Proteome Profiler Human Protease Array (ARY021B), Proteome Profiler Human Phospho-Kinase Array (ARY003C); Human MMP-13 DuoSet ELISA (DY511), Human Cathepsin-B DuoSet ELISA (DY2176) PYK2 inhibitor PF-431396 (4278) and GSK3α/β inhibitor SB 216763 (1616/1) were all purchased from R&D Systems (Abingdon, UK).

Techniques: Expressing, Activation Assay, Comparison, Control, Phospho-proteomics, Western Blot